MANILA, Philippines – The Professional Regulation Commission (PRC) Board of Medical Technology released the August 2016 Medical Technologist (MedTech) board exam room assignments one week before the licensure exam.
The board exam is scheduled to take place on August 27-28, 2016 at PRC testing centers in Manila, Baguio, Cebu, Cagayan de Oro, Davao, Iloilo, Legazpi and Lucena.
As posted by PRC, examinees shall bring the following requirements on examination proper. The Notice of Admission (NOA), Official Receipt, Pencils No. 1 or 2/ Black ink ballpen, metered stamped mailing envelope, long brown and plastic/transparent envelopes.
PRC reminds examinees to report before 6:30 in the morning on the said date because late comers will not be admitted, examination fees for late examinees will also be forfeited.
Examinees are advised to verify their application number on the day of examination from room watchers/proctors assigned to the room.
MedTech is one of the programs with average number of examinees being administered by PRC. On the same exam conducted March 2016, 2,046 out of 2,596 passed.
- List of Passers: August 2016 MedTech Board Exam Results
- Top 10 Passers: August 2016 MedTech Board Exam Topnotchers
- Top Performing Schools and Performance of Schools: August 2016 MedTech Board Exam Results
- Verification of Ratings: August 2016 MedTech Board Exam
Examinees shall adhere to the attire set by the Professional Regulation Commission.
For male examinees, plain white polo shirt with collar without any seal, logo or marks partnered with decent pants or slacks. For female, plain white blouse or shirt with collar without any seal, logo or marks partnered with skirt or slacks.
Below are the detailed program and room assignments for the testing locations mentioned in the August 2016 Licensure Exam for Medical Technologist (MedTech), courtesy of PRC:
To receive regular updates about August 2016 Medical Technologist (MedTech) board exam results as well as other related announcements, you may refer to our social media pages via Facebook and Twitter.